Study Shows Brain's Ability to Reorganize

Scientists from the UCLA Department of Neurology have confirmed that blindness causes structural changes in the brain, indicating that the brain may reorganize itself functionally in order to adapt to a loss in sensory input.

View

Good News on Multiple Sclerosis and Pregnancy

There is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS.

View

BIDMC Neuroscientists Awarded Grants from The Michael J. Fox Foundation for Parkinson’s Research

Beth Israel Deaconess Medical Center (BIDMC) neurologists Alvaro Pascual-Leone, MD, PhD, and Daniel Tarsy, MD, have been awarded grants totaling more than $1.5 million from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to conduct investigations aimed at improving the quality of life for patients with Parkinson’s disease.

View

Cognitive Dysfunction Reversed in Mouse Model of Down's Syndrome

A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the UCSD, School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down’s syndrome.

View

Neurodegenerative Disease Research Highlights from Annual Society for Neuroscience Meeting

The Web's leading source for research news on Alzheimer's and related neurodegenerative diseases reports from the world's largest annual gathering of neuroscientists.

View

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 11/23/2009 4:00 PM EST

Investigational Neurostimulation Device Aims to Reduce Stroke Damage

Stroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24.

View

Smoking May Now be Considered an Established Risk Factor for ALS

While previous studies have indicated a “probable” connection between smoking and ALS, a new study published in the Nov. 17, 2009 issue of Neurology®, the medical journal of the American Academy of Neurology, states smoking may now be considered an “established” risk factor for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease.

View

Analyzing Structural Brain Changes in Alzheimer’s Disease

In a study that promises to improve diagnosis and monitoring of Alzheimer’s disease, scientists at the University of California, San Diego have developed a fast and accurate method for quantifying subtle, sub-regional brain volume loss using magnetic resonance imaging (MRI). The study will be published the week of November 16 in the Proceedings of the National Academy of Science (PNAS).

View

Researchers to Test First Gene Therapy For Alzheimer’s Patients

Researchers are preparing for the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer’s disease. The study, the first multicenter neurosurgical intervention in Alzheimer’s research in the U.S., utilizes a viral-based gene transfer system, CERE-110, that makes Nerve Growth Factor (NGF), a naturally occurring protein that helps maintain nerve cell survival in the brain.

View